Barclays PLC Enochian Biosciences Inc Transaction History

Barclays PLC

$327 Billion
Q2 2024

A detailed history of Barclays PLC transactions in Enochian Biosciences Inc stock. As of the latest transaction made, Barclays PLC holds 16,727 shares of ENOB stock, worth $76,944. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,727

Holding current value

$76,944

% of portfolio

0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	N/A	16,727 New	16,727 $29,000
Q1 2023 May 04, 2023	BUY	$0.91 - $1.31 $4,105 - $5,910	4,512 Added 85.02%	9,819 $9,000
Q4 2022 Feb 13, 2023	BUY	$1.03 - $2.13 $4,603 - $9,518	4,469 Added 533.29%	5,307 $6,000
Q3 2022 Nov 03, 2022	SELL	$1.7 - $2.86 $260 - $437	-153 Reduced 15.44%	838 $2,000
Q2 2022 Aug 12, 2022	BUY	$1.93 - $8.73 $1,912 - $8,651	991 New	991 $2,000
Q3 2021 Nov 09, 2021	SELL	$4.56 - $7.88 $17,820 - $30,795	-3,908 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$2.94 - $6.79 $48,721 - $112,523	-16,572 Reduced 80.92%	3,908 $20,000
Q1 2021 May 13, 2021	BUY	$3.02 - $4.51 $21,378 - $31,926	7,079 Added 52.82%	20,480 $72,000
Q4 2020 Feb 11, 2021	BUY	$2.82 - $3.55 $19,971 - $25,141	7,082 Added 112.07%	13,401 $39,000
Q3 2020 Nov 12, 2020	SELL	$3.42 - $4.55 $4,709 - $6,265	-1,377 Reduced 17.89%	6,319 $23,000
Q2 2020 Aug 12, 2020	BUY	$2.78 - $6.06 $8,673 - $18,907	3,120 Added 68.18%	7,696 $33,000
Q1 2020 May 13, 2020	SELL	$2.08 - $5.41 $19,136 - $49,772	-9,200 Reduced 66.78%	4,576 $14,000
Q4 2019 Feb 10, 2020	BUY	$3.48 - $6.75 $41,053 - $79,629	11,797 Added 596.11%	13,776 $69,000
Q3 2019 Nov 14, 2019	SELL	$3.95 - $5.72 $2,409 - $3,489	-610 Reduced 23.56%	1,979 $11,000
Q2 2019 Aug 14, 2019	BUY	$4.5 - $6.99 $6,264 - $9,730	1,392 Added 116.29%	2,589 $12,000
Q1 2019 May 15, 2019	BUY	$5.82 - $9.25 $6,966 - $11,072	1,197 New	1,197 $8,000

Others Institutions Holding ENOB

# of Institutions

Shares Held

14M

Call Options Held

33.7K

Put Options Held

View Full List

About Enochian Biosciences Inc

Ticker ENOB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,950,000
Market Cap $244M
Description
Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...

More about ENOB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account